ISPC stock is currently trading at $4.07, up significantly due to securing a supplier for hMPV biospecimens, which aligns with rising demand in China. The bullish view anticipates further upside as the company capitalizes on this momentum, with a potential target of $5.50 if demand sustains. However, the stock remains speculative and highly volatile, requiring cautious monitoring.